ArticleZeitschrift fur Rheumatologie2026
[Revision of the model special training regulations 2026].
Article in Zeitschrift fur Rheumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The revision of the model special training regulations (Musterweiterbildungsordnung, MWBO), the federal template for training of specialists in internal medicine and rheumatology, occurs in the context of significant structural changes in the German healthcare system. Medical care structures will change, for inpatient care based on the Hospital Care Improvement Act (KHVVG) and the Hospital Reform Adjustment Act (KHAG), for outpatient care based on changes towards the primary care providers and all caregivers will have to adapt to the Health Insurance Premium Stabilization Act (BStabG). At the 130th German Federal Medical Assembly, an amendment was adopted for the MWBO with respect to training periods. The new MWBO maintains the total training period of 72 months for all internal medicine subspecialties but reduces the mandatory inpatient training period in the specialty from 24 to 18 months. In this context, the present article analyzes how the amended MWBO can ensure specialist training in rheumatology that is of high quality and fit for the future.
Indexed as
Identifiers
42789090What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.